# Chirag R. Parikh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chirag-r-parikh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 49,583 |
| Field | Acute Kidney Injury Research |
| h-index | 114 |
| i10-index | 469 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5040529362 |
| ORCID iD | https://orcid.org/0000-0001-9051-7385 |
| Works | 815 |

## Researcher papers

- [Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US](https://scholariq.org/papers/factors-associated-with-death-in-critically-ill-patients-with-coronavirus/)
- [KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2012-kdigo-clinical-practice-guideline-for-acute/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [An atlas of healthy and injured cell states and niches in the human kidney](https://scholariq.org/papers/an-atlas-of-healthy-and-injured-cell-states-and-niches-in-the-human-kidney/)
- [Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19](https://scholariq.org/papers/association-between-early-treatment-with-tocilizumab-and-mortality-among/)
- [Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine](https://scholariq.org/papers/outcomes-after-angiography-with-sodium-bicarbonate-and-acetylcysteine/)
- [Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial](https://scholariq.org/papers/automated-electronic-alerts-for-acute-kidney-injury-a-single-blind-parallel/)
- [AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19](https://scholariq.org/papers/aki-treated-with-renal-replacement-therapy-in-critically-ill-patients-with-covid/)
- [Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States](https://scholariq.org/papers/characteristics-and-outcomes-of-individuals-with-pre-existing-kidney-disease-and/)
- [Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19](https://scholariq.org/papers/thrombosis-bleeding-and-the-observational-effect-of-early-therapeutic/)

## Researcher topics

- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Trauma, Hemostasis, Coagulopathy, Resuscitation](https://scholariq.org/topics/trauma-hemostasis-coagulopathy-resuscitation-2/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.